Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry.
Genomewide association in early-onset breast cancer
Principal Investigator
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma. J Natl Cancer Inst. 2017 10 01; 109(10).
View in:
PubMed
subject areas
Case-Control Studies
Gene Amplification
Gene Expression Regulation, Neoplastic
Gene Frequency
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Neuroblastoma
N-Myc Proto-Oncogene Protein
Polymorphism, Single Nucleotide
authors with profiles
Mark Applebaum
Samuel Volchenboum
Susan Cohn